AORT vs BBNX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 17, 2026

AORT

32.3
AI Score
VS
BBNX Wins

BBNX

41.7
AI Score

Investment Advisor Scores

AORT

32score
Recommendation
SELL

BBNX

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AORT BBNX Winner
Revenue 242.09M 59.64M AORT
Net Income -12.09M -45.30M AORT
Gross Margin 64.4% 59.3% AORT
Net Margin -5.0% -76.0% AORT
Operating Income -2.58M -49.85M AORT
ROE -2.7% -17.7% AORT
ROA -1.1% -15.5% AORT
Total Assets 1.07B 292.39M AORT
Cash 77.32M 44.32M AORT
Current Ratio 3.47 8.88 BBNX
Free Cash Flow -18.86M -40.87M AORT

Relative Price Performance (Last 90 Days)

AORT 1M: +12.3% · 3M: +23.3% BBNX 1M: +18.1% · 3M: +79.5%

Current Technical Phase

AORT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.1% over 20 days), RSI 57

RSI (14): 57.3 · Price: $28.08

BBNX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.1% over 20 days), RSI 63

RSI (14): 63.0 · Price: $19.05

Fundamentals Snapshot

Metric AORT BBNX
Market Cap
Forward P/E 35.9 -8.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.4%
Gross Margin 0.6% 0.6%
Operating Margin 0.1% -0.8%
EPS -0.06 -1.56
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BBNX is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.